The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment †

SIMPLE SUMMARY: Biomarkers for the prediction and efficacy of therapies are an urgent necessity for lung cancer patients. In this article, we summarize genomic and proteomic biomarkers utilized for the early detection and treatment of lung cancer, with a focus on immune checkpoint and PI3K pathways....

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasian, Mohammad Hadi, Ardekani, Ali M., Sobhani, Navid, Roudi, Raheleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600051/
https://www.ncbi.nlm.nih.gov/pubmed/36291929
http://dx.doi.org/10.3390/cancers14205144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600051/
https://www.ncbi.nlm.nih.gov/pubmed/36291929
http://dx.doi.org/10.3390/cancers14205144

Ejemplares similares